The Royal Pharmaceutical Society
RPS PharmSci Today
Good podcast? Give it some love!
The Royal Pharmaceutical Society
RPS PharmSci TodayEpisodes
The Royal Pharmaceutical Society
RPS PharmSci Today
Good podcast? Give it some love!
Rate Podcast
Episodes of RPS PharmSci Today
Mark All
Search Episodes...
Gino is joined by James Rickard, Chief Scientific Officer of Biotherapy Services. James, a former Deputy Chief Pharmacist at The Royal London Hospital, has been developing new therapies that will allow pharmacists to successfully treat difficul
Gino is joined by James Rickard, Chief Scientific Officer of Biotherapy Services. James, a former Deputy Chief Pharmacist at The Royal London Hospital, has been developing new therapies that will allow pharmacists to successfully treat difficul
Gino is joined by RPS CEO Paul Bennett, and the two of them talk to Ian McCubbin OBE, Manufacturing Advisor for the UK Vaccine Taskforce, and former Senior Vice President for Global Manufacturing and Supply at GlaxoSmithKline. Ian shares his ob
In this episode, Gino talks to David Hipkiss, CEO of Enesi Pharma, about developments in solid dose formulation and needle-free delivery for vaccines. Vaccines have come under unprecedented scrutiny during the pandemic, and the two look at ways
This episode, Gino talks to Dr Derek O'Hagan, Senior Advisor Vaccines R&D at GlaxoSmithKline. A pharmacist and an expert on the formulation and delivery of vaccines, Derek, has been involved in the creation of vaccines all the way - from basic
It's a busy episode #26 of PharmSci Today, as Gino is joined by the NHS Lothian pharmacy team: Melinda Cuthbert, Claire Hannah, Jenny Scott, Julie Harrold, Fiona Clarke and Anne Neally. The team discuss their experiences of working through the
Gino is joined by Professor Chris Molloy, CEO of the Medicines Discovery Catapult, who gives his insider view of innovations in pharmacy and healthcare. The two discuss new ways to drive and support new developments in pharmacy, and examine how
This week's guest is Professor Jason Leitch, National Clinical Director of the Scottish Government and a Senior Clinical Advisor to the Scottish Government. Gino and Jason, along with RPS CEO Paul Bennett and RPS Director for Scotland Clare Mor
RPS Chief Scientist Gino Martini talks to Ravi Limaye, the Managing Director of medicine and vaccine specialists Wockhardt UK. They look at the science behind different vaccines and the challenges of manufacturing them in bulk, as well as the e
Dr Clive Dix, Head of Vaccine TaskForce, returns to answer questions on new variants, how the UK will have to use COVID-19 vaccines in the future - and the role of pharmacists' in tackling the pandemic. Hosted on Acast. See acast.com/privacy fo
With the development of vaccines for COVID-19 that require very low storage temperatures, cold chain management will be a vital part of any vaccine delivery system. RPS Chief Scientist Professor Gino Martini speaks to cold chain experts Michae
RPS Chief Scientist Professor Gino Martini speaks to Dr Clive Dix, Deputy Chair of the UK's Vaccine Taskforce. They look at the UK's plans for developing a COVID-19 vaccine: the different options and likelihood of success, as well as the diffic
RPS Chief Scientist Professor Gino Martini speaks to Dr Clive Dix, Deputy Chair of the UK's Vaccine Taskforce. They look at the UK's plans for developing a COVID-19 vaccine: the different options and likelihood of success, as well as the diffic
Gino and Sarah continue their chat with Oksana Pyzik, UCL Lead of Global Citizenship Programme on Outbreaks of Infectious Diseases. Oksana is one of the creators of Fight the Fakes, a campaign to raise awareness about the dangers of fake medici
Gino and Sarah continue their chat with Oksana Pyzik, UCL Lead of Global Citizenship Programme on Outbreaks of Infectious Diseases. Oksana is one of the creators of Fight the Fakes, a campaign to raise awareness about the dangers of fake medici
Join Gino and Sarah for the first part of their chat with Oksana Pyzik, UCL Lead of Global Citizenship Programme on Outbreaks of Infectious Diseases. Oksana is one of the creators of Fight the Fakes, a campaign to raise awareness about the dang
Join Gino and Sarah for the first part of their chat with Oksana Pyzik, UCL Lead of Global Citizenship Programme on Outbreaks of Infectious Diseases. Oksana is one of the creators of Fight the Fakes, a campaign to raise awareness about the dang
Gino and Sarah talk to Dave Tudor, Managing Director of the Medicines Manufacturing Innovation Centre at CPI (Centre for Process Innovation). As the COVID-19 pandemic continues they look at how the pharmaceutical industry has accelerated and in
Gino and Sarah talk to Dave Tudor, Managing Director of the Medicines Manufacturing Innovation Centre at CPI (Centre for Process Innovation). As the COVID-19 pandemic continues they look at how the pharmaceutical industry has accelerated and in
Gino and Sarah talk to Dr Daria Donati, Head of Business Development & Strategic Technology Partnerships at Cytiva. They discuss the prospects for a COVID-19 vaccine in the UK supported by VMIC, the Vaccines Manufacturing and Innovation Centre,
Gino and Sarah talk to Dr Daria Donati, Head of Business Development & Strategic Technology Partnerships at Cytiva. They discuss the prospects for a COVID-19 vaccine in the UK supported by VMIC, the Vaccines Manufacturing and Innovation Centre,
Gino and Sarah talk to Chas Bountra, Professor of Translational Medicine in the Nuffield Department of Clinical Medicine and Associate Member of the Department of Pharmacology at the University of Oxford. The first working COVID vaccine could c
Gino and Sarah talk to Chas Bountra, Professor of Translational Medicine in the Nuffield Department of Clinical Medicine and Associate Member of the Department of Pharmacology at the University of Oxford. The first working COVID vaccine could c
Gino and Sarah talk to Warwick Smith, Director General of the British Generic Manufacturers Association, about the effects COVID-19 has had on the pharmaceutical industry, as well as when and how a vaccine or treatment is likely to become avail
Gino and Sarah talk to Warwick Smith, Director General of the British Generic Manufacturers Association, about the effects COVID-19 has had on the pharmaceutical industry, as well as when and how a vaccine or treatment is likely to become avail
Join Podchaser to...
- Rate podcasts and episodes
- Follow podcasts and creators
- Create podcast and episode lists
- & much more
Unlock more with Podchaser Pro
- Audience Insights
- Contact Information
- Demographics
- Charts
- Sponsor History
- and More!
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2024 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us